Antuofei ® Celecoxib capsules
Selected in the 3rd Round of National Volume-Based Procurement
Category B under National Medical Insurance
[Drug Name]
Generic name: Celecoxib Capsules
[Indications]
For relief of the signs and symptoms of osteoarthritis, relief of signs and symptoms of adult rheumatoid arthritis, treatment of acute pain in adults, and relief of signs and symptoms of ankylosing spondylitis.
[Dosage and Adminstration]
• Osteoarthritis: 200 mg orally, twice daily.
• Rheumatoid arthritis: 200 mg orally, twice daily.
• Acute pain: On Day 1, initial dose 400 mg; an additional 200 mg may be taken if needed. Thereafter, 200 mg orally twice daily as required.
• Ankylosing spondylitis: 200 mg orally, once daily. If no effect after 6 weeks, may increase to 400 mg daily. If still ineffective after 6 weeks at 400 mg, alternative treatment should be considered.
[ Contraindications ]
Contraindicated in patients allergic to celecoxib. Not for use in patients with known sulfonamide allergy. Contraindicated in patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Contraindicated for perioperative pain in patients undergoing coronary artery bypass graft (CABG) surgery. See package insert for details.
[Specification]
0.2 g
[Shelf Life]
36 months
[Approval Number]
National Medical Products Administration Approval Number: H20213779
Fujian Haixi New Pharmaceutical Creation Co., Ltd. Fujian ICP Record No. 12015727 Internet Drug Information Service Qualification Certificate No.: (Min) - Non-operating-2023-0063
Some of the text and pictures on this site are from the Internet and are only used for sharing and learning. If your rights and interests are infringed, please inform us in time, and this site will deal with or replace them in time.
